logo
DNA logo

Ginkgo Bioworks Holdings Community

NYSE:DNA Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 49 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

DNA
Ginkgo Bioworks Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts

Biopharma Demand Will Boost Automation And Data Services

Key Takeaways Shifting towards tools like Ginkgo Automation platform addresses biopharma AI data demand, enhancing revenue through diversification. Expanding customer base and government partnerships in Cell Engineering and Biosecurity aim for sustained revenue growth.
View narrative
US$8.30
FV
3.4% overvalued intrinsic discount
-0.039%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
46users have followed this narrative
16 days ago author updated this narrative